| Conferences \ BioProcessing, Biologics & Biotherapeutics Congress \ Antibody and Peptide Therapeutics \ Agenda \ Thomas Schirrmann |
| Register | Login |
Antibodies and Antibody RNase Fusion Proteins Targeting CD30+ LymphomaWednesday, 20 July 2011 at 11:15  Add to Calendar ▼2011-07-20 11:15:002011-07-20 12:15:00Europe/LondonAntibodies and Antibody RNase Fusion Proteins Targeting CD30+ LymphomaSELECTBIOenquiries@selectbiosciences.comCD30 specific recombinant human antibodies and immunoRNases are produced in high levels using mammalian cell lines. Antibodies as well as immunoRNases mediate inhibitory effects on Hodgkin lymphoma cell lines but immunoRNases show higher efficacy. |
Add to Calendar ▼2011-07-20 00:00:002011-07-21 00:00:00Europe/LondonAntibody and Peptide TherapeuticsSELECTBIOenquiries@selectbiosciences.com
